XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Other Intangible Assets
 3 Months Ended
Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS
NOTE C – GOODWILL AND OTHER INTANGIBLE ASSETS

The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:
As of March 31, 2022As of December 31, 2021
(in millions)Gross Carrying AmountAccumulated Amortization/ Write-offsGross Carrying AmountAccumulated Amortization/ Write-offs
Technology-related$12,559 $(6,918)$11,957 $(6,754)
Patents489 (393)494 (398)
Other intangible assets1,946 (1,347)1,900 (1,325)
Amortizable intangible assets$14,994 $(8,659)$14,351 $(8,476)
    
Goodwill$22,849 $(9,900)$21,888 $(9,900)
IPR&D$126 $126 
Technology-related120 120 
Indefinite-lived intangible assets$246 $246 
The increase in our balance of goodwill and intangible assets is primarily related to our acquisition of Baylis Medical completed in the first quarter of 2022.

The following represents our goodwill balance by global reportable segment:
(in millions)MedSurgCardiovascularTotal
As of December 31, 2021$4,246 $7,741 $11,988 
Impact of foreign currency fluctuations and other changes in carrying value(2)(24)(27)
Goodwill acquired— 988 988 
As of March 31, 2022$4,244 $8,705 $12,949 

In the first quarter of 2022, we reorganized our operational structure in order to strengthen our category leadership in the markets we serve and, in particular, benefit our Cardiology customers and patients. Following the reorganization, we have aggregated our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. We have revised prior periods to conform to the current year presentation.

We did not record any goodwill or intangible asset impairment charges in the first quarter of 2022 or 2021. Refer to Note A – Basis of Presentation to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.